KHAN SADIQ (Chief Commercial Officer) received a stock award from TEVOGEN BIO HOLDINGS INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 2/16/2024ACC: 0001062993-24-003489
Officer· Chief Commercial Officer
Since Feb 2024
+969.62K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
1
Total transactions
969.62K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+969.62K
Price / share
—
Trade value
—
% of position
New position
2/14/2024
0.00→969.62K
Total
Net shares
+969.62K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/14/2024 | A · Award | +969.62K | — | — | New position | 0.00 | 969.62K |
| Total | +969.62K | $0.00 | ||||||
Derivative Transactions0
No derivative transactions reported